Nearly seven years after the FDA approved Novo Nordisk’s Ozempic for diabetes treatment, this medication and other GLP-1 receptor agonists have proven very effective in promoting weight loss. For the ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced today that our ...

BullFrog AI Holdings, Inc. has introduced bfLEAP™, an advanced platform designed to enhance the drug development process in biopharma by utilizing AI and machine learning for greater predictive ...

As drug costs rise and public trust falls, A.I. may transform the economics of clinical trials—and reshape the future of pharma. Unsplash+ Sixty percent of the total U.S. population takes at least one ...

SHELTON, CT / ACCESS Newswire / July 21, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of ...

Recursion Pharmaceuticals leverages AI and machine learning to revolutionize drug discovery, reducing costs and accelerating development, positioning itself as a leader in tech-driven biopharma. The ...

The real “commercial launch” happens years before launch preparation officially begins. Once Phase III begins, your evidence ...

Getz K, Barr E. Aligning Purpose, Innovation, and Operational Excellence in Clinical Development. SCOPE Summit 2026. February 3, 2026. Stay current in clinical research with Applied Clinical Trials, ...

A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...

For biotech companies the past two years have been challenging. Biotech investments have not reached the record levels of ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...